Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Atlanta Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 12, 2025, 10:12 am

Market Cap 207 Cr.
Current Price 25.4
High / Low27.1/10.3
Stock P/E
Book Value 6.43
Dividend Yield0.00 %
ROCE0.67 %
ROE%
Face Value 2.00
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Atlanta Ltd

Competitors of Atlanta Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Gujarat Metallic Coal & Coke Ltd 5.94 Cr. 30.0 / 77.60.00 %0.37 %2.00 % 100
Gensol Engineering Ltd 1,107 Cr. 291 1,126/29012.8 1550.00 %14.3 %20.1 % 10.0
Gagan Polycot India Ltd 0.86 Cr. 0.86/ 4.080.00 %81.2 %81.2 % 10.0
Fusion Micro Finance Ltd 1,516 Cr. 150 544/140 2510.00 %14.1 %19.6 % 10.0
Five X Tradecom Ltd 0.99 Cr. 0.48/ 9.350.00 %0.00 %0.00 % 10.0
Industry Average5,442.36 Cr202.43227.27107.920.30%21.47%71.79%9.42

All Competitor Stocks of Atlanta Ltd

Quarterly Result

MetricSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales 911608491213112122341413
Expenses 1152538884231059856
Operating Profit -2635640-77-2913714-487
OPM % -18%58%58%68%83%-645%-222%22%57%60%-105%61%57%
Other Income 1-02032104422222314
Interest 151522157110-32014111
Depreciation 10101066667771099
Profit before tax -26-194-15-511-261-316-131311
Tax % 1%3%109%1%-40%7%-3%0%0%0%-180%0%0%
Net Profit -25-19-0-15-710-270-316-361311
EPS in Rs -3.11-2.30-0.05-1.79-0.901.27-33.15-0.320.070.70-4.420.1638.07

Last Updated: Unknown

Below is a detailed analysis of the quarterly data for Atlanta Ltd based on the most recent figures (Sep 2023) and their trends compared to the previous period:

  • For Sales, as of Sep 2023, the value is ₹13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Jun 2023) to ₹13.00 Cr., marking a decrease of 1.00 Cr..
  • For Expenses, as of Sep 2023, the value is ₹6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Jun 2023) to ₹6.00 Cr., marking an increase of ₹1.00 Cr..
  • For Operating Profit, as of Sep 2023, the value is ₹7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Jun 2023) to ₹7.00 Cr., marking a decrease of 1.00 Cr..
  • For OPM %, as of Sep 2023, the value is 57.00%. The value appears to be declining and may need further review. It has decreased from 61.00% (Jun 2023) to 57.00%, marking a decrease of 4.00%.
  • For Other Income, as of Sep 2023, the value is ₹314.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Jun 2023) to ₹314.00 Cr., marking an increase of ₹312.00 Cr..
  • For Interest, as of Sep 2023, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 1.00 Cr..
  • For Depreciation, as of Sep 2023, the value is ₹9.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 9.00 Cr..
  • For Profit before tax, as of Sep 2023, the value is ₹311.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Jun 2023) to ₹311.00 Cr., marking an increase of ₹310.00 Cr..
  • For Tax %, as of Sep 2023, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 0.00%.
  • For Net Profit, as of Sep 2023, the value is ₹311.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Jun 2023) to ₹311.00 Cr., marking an increase of ₹310.00 Cr..
  • For EPS in Rs, as of Sep 2023, the value is 38.07. The value appears strong and on an upward trend. It has increased from ₹0.16 (Jun 2023) to 38.07, marking an increase of ₹37.91.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Metric

Profit & Loss Yearly Chart

Unable to calculate YoY Net Profit Growth.

No data available for the compounded sales growth chart.

No data available for the Balance Sheet data table.

Reserves and Borrowings Chart

No data available for this post.

Free Cash Flow

Month
Free Cash Flow

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days126356314620616031271577258173359
Inventory Days8105281,4426749741,646878
Days Payable856339920666193327206
Cash Conversion Cycle8135633357281691,0932,034749258173359
Working Capital Days-161-3155170-573-28193-174-436206221865
ROCE %4%8%9%7%1%6%2%-1%1%0%-40%-1%

Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) -3.98-49.38-8.61-97.96-11.29
Diluted EPS (Rs.) -3.98-49.38-8.61-97.96-11.29
Cash EPS (Rs.) -0.20-46.30-3.61-93.37-6.85
Book Value[Excl.RevalReserv]/Share (Rs.) -47.10-40.56-69.60-60.4737.23
Book Value[Incl.RevalReserv]/Share (Rs.) -47.10-40.56-69.60-60.4737.23
Revenue From Operations / Share (Rs.) 6.3428.7710.8411.815.92
PBDIT / Share (Rs.) 3.39-22.255.085.642.33
PBIT / Share (Rs.) -0.37-25.340.081.06-2.12
PBT / Share (Rs.) -1.13-47.93-7.94-97.47-11.35
Net Profit / Share (Rs.) -3.98-49.38-8.61-97.96-11.29
NP After MI And SOA / Share (Rs.) -3.98-49.38-8.61-97.96-11.29
PBDIT Margin (%) 53.44-77.3346.8747.7739.30
PBIT Margin (%) -5.97-88.050.738.96-35.77
PBT Margin (%) -17.82-166.59-73.27-825.66-191.93
Net Profit Margin (%) -62.72-171.63-79.40-829.73-190.85
NP After MI And SOA Margin (%) -62.72-171.63-79.40-829.73-190.85
Return on Networth / Equity (%) 0.000.000.000.00-30.42
Return on Capital Employeed (%) 1.0490.43-0.27-6.64-1.38
Return On Assets (%) -6.25-70.72-9.64-107.58-5.65
Long Term Debt / Equity (X) -0.04-0.09-0.35-0.502.78
Total Debt / Equity (X) -2.12-2.42-1.54-1.853.34
Asset Turnover Ratio (%) 0.030.380.020.030.01
Current Ratio (X) 0.270.280.130.100.50
Quick Ratio (X) 0.210.220.080.040.33
Inventory Turnover Ratio (X) 0.000.080.130.350.12
Interest Coverage Ratio (X) 4.51-2.850.630.680.25
Interest Coverage Ratio (Post Tax) (X) -4.30-3.43-0.070.07-0.22
Enterprise Value (Cr.) 854.24910.44932.51943.761164.57
EV / Net Operating Revenue (X) 16.543.8810.569.8124.15
EV / EBITDA (X) 30.95-5.0222.5220.5361.46
MarketCap / Net Operating Revenue (X) 2.420.670.600.243.13
Price / BV (X) -0.32-0.47-0.09-0.040.49
Price / Net Operating Revenue (X) 2.420.670.600.243.13
EarningsYield -0.25-2.53-1.32-33.89-0.61

After reviewing the key financial ratios for Atlanta Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 23, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.00.
  • For Basic EPS (Rs.), as of Mar 23, the value is -3.98. This value is below the healthy minimum of 5. It has increased from -49.38 (Mar 22) to -3.98, marking an increase of 45.40.
  • For Diluted EPS (Rs.), as of Mar 23, the value is -3.98. This value is below the healthy minimum of 5. It has increased from -49.38 (Mar 22) to -3.98, marking an increase of 45.40.
  • For Cash EPS (Rs.), as of Mar 23, the value is -0.20. This value is below the healthy minimum of 3. It has increased from -46.30 (Mar 22) to -0.20, marking an increase of 46.10.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is -47.10. It has decreased from -40.56 (Mar 22) to -47.10, marking a decrease of 6.54.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is -47.10. It has decreased from -40.56 (Mar 22) to -47.10, marking a decrease of 6.54.
  • For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 6.34. It has decreased from 28.77 (Mar 22) to 6.34, marking a decrease of 22.43.
  • For PBDIT / Share (Rs.), as of Mar 23, the value is 3.39. This value is within the healthy range. It has increased from -22.25 (Mar 22) to 3.39, marking an increase of 25.64.
  • For PBIT / Share (Rs.), as of Mar 23, the value is -0.37. This value is below the healthy minimum of 0. It has increased from -25.34 (Mar 22) to -0.37, marking an increase of 24.97.
  • For PBT / Share (Rs.), as of Mar 23, the value is -1.13. This value is below the healthy minimum of 0. It has increased from -47.93 (Mar 22) to -1.13, marking an increase of 46.80.
  • For Net Profit / Share (Rs.), as of Mar 23, the value is -3.98. This value is below the healthy minimum of 2. It has increased from -49.38 (Mar 22) to -3.98, marking an increase of 45.40.
  • For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is -3.98. This value is below the healthy minimum of 2. It has increased from -49.38 (Mar 22) to -3.98, marking an increase of 45.40.
  • For PBDIT Margin (%), as of Mar 23, the value is 53.44. This value is within the healthy range. It has increased from -77.33 (Mar 22) to 53.44, marking an increase of 130.77.
  • For PBIT Margin (%), as of Mar 23, the value is -5.97. This value is below the healthy minimum of 10. It has increased from -88.05 (Mar 22) to -5.97, marking an increase of 82.08.
  • For PBT Margin (%), as of Mar 23, the value is -17.82. This value is below the healthy minimum of 10. It has increased from -166.59 (Mar 22) to -17.82, marking an increase of 148.77.
  • For Net Profit Margin (%), as of Mar 23, the value is -62.72. This value is below the healthy minimum of 5. It has increased from -171.63 (Mar 22) to -62.72, marking an increase of 108.91.
  • For NP After MI And SOA Margin (%), as of Mar 23, the value is -62.72. This value is below the healthy minimum of 8. It has increased from -171.63 (Mar 22) to -62.72, marking an increase of 108.91.
  • For Return on Networth / Equity (%), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 22) which recorded 0.00.
  • For Return on Capital Employeed (%), as of Mar 23, the value is 1.04. This value is below the healthy minimum of 10. It has decreased from 90.43 (Mar 22) to 1.04, marking a decrease of 89.39.
  • For Return On Assets (%), as of Mar 23, the value is -6.25. This value is below the healthy minimum of 5. It has increased from -70.72 (Mar 22) to -6.25, marking an increase of 64.47.
  • For Long Term Debt / Equity (X), as of Mar 23, the value is -0.04. This value is below the healthy minimum of 0.2. It has increased from -0.09 (Mar 22) to -0.04, marking an increase of 0.05.
  • For Total Debt / Equity (X), as of Mar 23, the value is -2.12. This value is within the healthy range. It has increased from -2.42 (Mar 22) to -2.12, marking an increase of 0.30.
  • For Asset Turnover Ratio (%), as of Mar 23, the value is 0.03. It has decreased from 0.38 (Mar 22) to 0.03, marking a decrease of 0.35.
  • For Current Ratio (X), as of Mar 23, the value is 0.27. This value is below the healthy minimum of 1.5. It has decreased from 0.28 (Mar 22) to 0.27, marking a decrease of 0.01.
  • For Quick Ratio (X), as of Mar 23, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 22) to 0.21, marking a decrease of 0.01.
  • For Inventory Turnover Ratio (X), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.08 (Mar 22) to 0.00, marking a decrease of 0.08.
  • For Interest Coverage Ratio (X), as of Mar 23, the value is 4.51. This value is within the healthy range. It has increased from -2.85 (Mar 22) to 4.51, marking an increase of 7.36.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is -4.30. This value is below the healthy minimum of 3. It has decreased from -3.43 (Mar 22) to -4.30, marking a decrease of 0.87.
  • For Enterprise Value (Cr.), as of Mar 23, the value is 854.24. It has decreased from 910.44 (Mar 22) to 854.24, marking a decrease of 56.20.
  • For EV / Net Operating Revenue (X), as of Mar 23, the value is 16.54. This value exceeds the healthy maximum of 3. It has increased from 3.88 (Mar 22) to 16.54, marking an increase of 12.66.
  • For EV / EBITDA (X), as of Mar 23, the value is 30.95. This value exceeds the healthy maximum of 15. It has increased from -5.02 (Mar 22) to 30.95, marking an increase of 35.97.
  • For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 2.42. This value is within the healthy range. It has increased from 0.67 (Mar 22) to 2.42, marking an increase of 1.75.
  • For Price / BV (X), as of Mar 23, the value is -0.32. This value is below the healthy minimum of 1. It has increased from -0.47 (Mar 22) to -0.32, marking an increase of 0.15.
  • For Price / Net Operating Revenue (X), as of Mar 23, the value is 2.42. This value is within the healthy range. It has increased from 0.67 (Mar 22) to 2.42, marking an increase of 1.75.
  • For EarningsYield, as of Mar 23, the value is -0.25. This value is below the healthy minimum of 5. It has increased from -2.53 (Mar 22) to -0.25, marking an increase of 2.28.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Error: Data is incomplete for fair value calculation.

Strength and Weakness

Unable to fetch valid data for stock valuation.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Atlanta Ltd:
    1. Net Profit Margin: -62.72%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 1.04% (Industry Average ROCE: 21.47%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 0% (Industry Average ROE: 71.79%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): -4.3
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.21
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 0 (Industry average Stock P/E: 227.27)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: -2.12
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

No data availabale for About the Company
INDUSTRYADDRESSCONTACT
Industry not foundAddress not foundContact not found
Management Data not Available

FAQ

What is the latest intrinsic value of Atlanta Ltd?

The latest intrinsic value of Atlanta Ltd is ₹0.00.

What is the Market Cap of Atlanta Ltd?

The Market Cap of Atlanta Ltd is 207 Cr..

What is the current Stock Price of Atlanta Ltd as on 14 November 2024?

The current stock price of Atlanta Ltd as on 14 November 2024 is ₹25.4.

What is the High / Low of Atlanta Ltd stocks in FY 2024?

In FY 2024, the High / Low of Atlanta Ltd stocks is 27.1/10.3.

What is the Stock P/E of Atlanta Ltd?

The Stock P/E of Atlanta Ltd is .

What is the Book Value of Atlanta Ltd?

The Book Value of Atlanta Ltd is 6.43.

What is the Dividend Yield of Atlanta Ltd?

The Dividend Yield of Atlanta Ltd is 0.00 %.

What is the ROCE of Atlanta Ltd?

The ROCE of Atlanta Ltd is 0.67 %.

What is the ROE of Atlanta Ltd?

The ROE of Atlanta Ltd is %.

What is the Face Value of Atlanta Ltd?

The Face Value of Atlanta Ltd is 2.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Atlanta Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE